mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.5 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.5 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |